article

1. Impact of Hospitalizations on Problematic Medication Use Among Community-Dwelling Persons With Dementia..  The journals of gerontology. Series A, Biological sciences and medical sciences.  79. 2024
2. Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults..  JAMA.  332:252-254. 2024
3. From bedside-to-model: Designing clinical prediction rules for implementation..  Journal of the American Geriatrics Society.  72:1654-1657. 2024
4. Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid-loop diuretic cascade..  Journal of the American Geriatrics Society.  72:1728-1740. 2024
5. Development and External Validation of Models to Predict Need for Nursing Home Level of Care in Community-Dwelling Older Adults With Dementia..  JAMA internal medicine.  184:81-91. 2024
6. Around the EQUATOR with Clin-STAR: Prediction modeling opportunities and challenges in aging research..  Journal of the American Geriatrics Society.  72:1658-1668. 2023
7. Frequency of Screening for Colorectal Cancer by Predicted Life Expectancy Among Adults 76-85 Years..  JAMA.  330:1280-1282. 2023
8. Incorporating Prognosis into Clinical Decision-Making for Older Adults with Diabetes..  Journal of general internal medicine.  38:2857-2859. 2023
9. Medication misuse and overuse in community-dwelling persons with dementia..  Journal of the American Geriatrics Society.  71:3086-3098. 2023
10. Improving Clinical Applicability of Mortality Prediction Models Among Persons With Dementia-Reply..  JAMA internal medicine.  183:-. 2023
11. Development and External Validation of a Mortality Prediction Model for Community-Dwelling Older Adults With Dementia..  JAMA internal medicine.  182:1161-1170. 2022
12. Fingerstick glucose monitoring by cognitive impairment status in Veterans Affairs nursing home residents with diabetes..  Journal of the American Geriatrics Society.  70:3176-3184. 2022
13. Do functional status and Medicare claims data improve the predictive accuracy of an electronic health record mortality index? Findings from a national Veterans Affairs cohort..  BMC geriatrics.  22:-. 2022
14. Comparing Machine Learning to Regression Methods for Mortality Prediction Using Veterans Affairs Electronic Health Record Clinical Data..  Medical care.  60:470-479. 2022
15. Mild cognitive impairment as a clinical and research outcome: Ready for prime time?.  Journal of the American Geriatrics Society.  70:1361-1364. 2022
16. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials..  JAMA internal medicine.  182:33-41. 2022
17. COVID-19, masks, and hearing difficulty: Perspectives of healthcare providers..  Journal of the American Geriatrics Society.  69:2783-2785. 2021
18. Hospitalization Risk Among Older Adults with Sensory Impairments: Development of a Prognostic Model..  Journal of the American Geriatrics Society.  68:2650-2655. 2020
19. Regulation of Iron Homeostasis through Parkin-Mediated Lactoferrin Ubiquitylation..  Biochemistry.  59:2916-2921. 2020
20. Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults..  Journal of the American Geriatrics Society.  67:1617-1624. 2019
21. Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia..  Handbook of clinical neurology.  5-32. 2019
22. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease..  Drug design, development and therapy.  3267-3279. 2016
23. Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease..  Expert opinion on pharmacotherapy.  17:1789-800. 2016
24. Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics..  Expert review of neurotherapeutics.  17:17-32. 2016
25. Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease..  Expert opinion on pharmacotherapy.  17:861-70. 2016
26. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease..  Drugs & aging.  32:537-47. 2015
27. Tctex1d2 associates with short-rib polydactyly syndrome proteins and is required for ciliogenesis..  Cell cycle (Georgetown, Tex.).  14:1116-25. 2015
28. Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication..  Expert review of neurotherapeutics.  15:7-17. 2014
29. A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine..  Expert opinion on pharmacotherapy.  15:2525-42. 2014